UBS AM’s Pactiv Evergreen PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-105,861
| Closed | -$1.91M | – | 2745 |
|
|
2025
Q1 | $1.91M | Buy |
105,861
+706
| +0.7% | +$12.6K | ﹤0.01% | 2013 |
|
|
2024
Q4 | $1.84M | Buy |
105,155
+26,705
| +34% | +$361K | ﹤0.01% | 2093 |
|
|
2024
Q3 | $903K | Sell |
78,450
-21,078
| -21% | -$242K | ﹤0.01% | 2447 |
|
|
2024
Q2 | $1.13M | Buy |
99,528
+44,797
| +82% | +$596K | ﹤0.01% | 2314 |
|
|
2024
Q1 | $784K | Buy |
54,731
+20,059
| +58% | +$284K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $475K | Hold |
34,672
| – | – | ﹤0.01% | 2335 |
|
|
2023
Q3 | $282K | Hold |
34,672
| – | – | ﹤0.01% | 2450 |
|
|
2023
Q2 | $277K | Hold |
34,672
| – | – | ﹤0.01% | 2495 |
|
|
2023
Q1 | $277K | Sell |
34,672
-21,956
| -39% | -$226K | ﹤0.01% | 2495 |
|
|
2022
Q4 | $643K | Buy |
56,628
+19,902
| +54% | +$217K | ﹤0.01% | 2069 |
|
|
2022
Q3 | $321K | Buy |
+36,726
| New | +$381K | ﹤0.01% | 2479 |
|
UBS AM's PTVE Position: Q2 2025 in Review
UBS AM sold out of Pactiv Evergreen (PTVE) in Q2 2025, closing a stake of 105,861 shares — an estimated $1.91M sold.
UBS AM first reported a position in PTVE in Q3 2022 and held it in 11 quarters. The position peaked at $1.91M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- UBS AM reported no remaining Pactiv Evergreen position as of Q2 2025 after selling out during the quarter.
- UBS AM sold 105,861 Pactiv Evergreen shares in Q2 2025, an estimated $1.91M.
- UBS AM first reported a position in Pactiv Evergreen in Q3 2022 and held it in 11 quarters.
- UBS AM's Pactiv Evergreen position peaked at $1.91M in Q1 2025.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen as of Q2 2025.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.